Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001865778-25-000003
Filing Date
2025-09-05
Accepted
2025-09-05 18:34:20
Documents
1
Period of Report
2025-09-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1757111657.html 4  
1 FORM 4 wk-form4_1757111657.xml 4 3941
  Complete submission text file 0001865778-25-000003.txt   5493
Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Issuer) CIK: 0001808805 (see all company filings)

EIN.: 981541723 | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O NAUTILUS BIOTECHNOLOGY, INC. 425 PONTIUS AVE N, STE 202 SEATTLE WA 98109
Business Address
Murphy Matthew B. (Reporting) CIK: 0001865778 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39434 | Film No.: 251298234